Image Trademark of Agilent Technologies, Inc. Trademark Details
Status | Alive Registered 700 — Registered |
---|
Current Owner
Agilent Technologies, Inc. of Santa Clara, CA
View all trademarks for Agilent Technologies, Inc.Serial Number | 85832109 |
---|---|
Registration Number | 4406176 |
Status Date | Tuesday, September 24, 2013 |
Filing Date | Tuesday, September 24, 2013 |
Registration Date | Tuesday, September 24, 2013 |
Attorney | Scott S. Havlick |
Correspondent
SCOTT S. HAVLICK
HOLLAND & HART LLP
PO BOX 8749
DENVER, CO 80201-8749
HOLLAND & HART LLP
PO BOX 8749
DENVER, CO 80201-8749
Case File Statements
Indication of Colors | Color is not claimed as a feature of the mark. |
---|---|
Description of Mark | The mark consists of stylized eight-pointed star formed by shaded circles. |
Goods & Services | House mark for a full line of reagents for scientific or medical research use; house mark for a full line of chemicals for scientific purposes used in spectroscopy, mass spectrometry, chromatography and electrophoresis and for sample preparation for spectroscopy, mass spectrometry, chromatography and electrophoresis; chemicals used in industry and science, namely, for use in spectroscopy, mass spectrometry, chromatography, or electrophoresis or in sample preparation for spectroscopy, mass spectrometry, chromatography, or electrophoresis including standards all for scientific, clinical and scientific research use; reagents for scientific and research use; aqueous and organic solvents in the nature of chemical preparations for scientific and research use; cleaning detergents for industrial use, namely, for scientific and research use; chemicals for scientific purposes, namely, calibrants for performance verification of scientific instrumentation; ampholytes, namely, chemical products in the nature of preparations for scientific use for use in the separation and purification of any charge carrying molecule such as proteins and other molecules of biological origin as well as synthetic chemicals, these products being carrier ampholytes designed for use in isoelectric focusing, isotachophoresis and iso exchange chromatograph; chemicals, namely, buffer and standard solutions used in analytical chemistry; catalysts for chemical and biochemical processes; reagents, namely, matrices for scientific or medical research use; electrophoresis gels other than for medical or veterinary purposes; chromatography chemicals, namely, silica gel, polymers and solvents all for use in chromatography; purifying filtering and absorbing chemicals for use in industry, including for scientific and research use. solid phase extraction chemicals for use in the chromatography industry; chemical and biological standards, namely, chemical reagents for scientific and research use used in DNA, RNA and protein analysis; reagents for research purposes for scientific or medical research use; DNA labeling reagents for research purposes; DNA hybridization buffers, namely, reagents for research purposes for use in DNA hybridization; DNA cloning vectors, namely, reagents for scientific and research use; genomic cloning vectors, namely, reagents for scientific and research use; eukaryotic expression vectors, namely, reagents for scientific and research use; prokaryotic expression vectors, namely, reagents for scientific and research use; yeast shuttle vectors, namely, reagents for scientific and research use; competent cells, namely, reagents for scientific and research use; host cells, namely, reagents for scientific and research use; scientific and research laboratory reagents for molecular biological use, namely, packaging extracts used for inserting DNA into phages; polymerase chain reaction or PCR related products, namely, reagents for scientific and research use; nucleic acid markers, namely, reagents for scientific and research use; reagents used as protein standards for scientific, medical and research use; reagents used as synthetic peptide and protein digest standards for scientific and research use; reagents, namely, DNA primers and DNA vectors for scientific and research use; modifying enzymes not for medical use, namely, polymerase, nucleases, reverse transcriptases, ligases, kinases, phosphatases, glycosylases and transferases for scientific and research use; restriction enzymes for scientific and research use; media supplements, namely, reagents for scientific and research use. lymphokines, namely, reagents for scientific and research use; cytokines, namely, reagents for scientific and research use; kits for molecular biological research, namely, DNA cloning kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, genomic cloning kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, transfection kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, purification kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, polymerase chain reaction or PCR related cloning kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, ligase chain reaction or LCR kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, library construction kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, labeling kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, sequencing kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, mutagenesis kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors. kits for scientific and research use, namely, protein analysis kits said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, transcription kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, translation kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; and kits for molecular biological research, namely, in situ hybridization kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors |
Classifications
International Class Codes |
001
|
---|---|
U.S. Class Codes | 001, 005, 006, 010, 026, 046 |
Status | 6 — Active |
Status Date | Wednesday, January 30, 2013 |
First Use Anywhere | Monday, November 1, 1999 |
First Use In Commerce | Monday, November 1, 1999 |
Primary Code | 001 |
Trademark Timeline
-
Nov 01 1999First use anywhere for the mark
-
Nov 01 1999First use in commerce for the mark
-
Jan 25 2013Trademark application filed with USPTO
-
Jan 29 2013New Application Entered In Tram
-
Jan 29 2013International filing request made
-
Jan 29 2013New Application For Ir Received
-
Jan 30 2013New Application Office Supplied Data Entered In Tram
-
Jan 30 2013Manually Certified
-
Jan 30 2013Ir Certified and Sent To Ib
-
Jan 31 2013Notice of Design Search Code Mailed
-
May 09 2013Assigned To Examiner
-
May 16 2013Approved For Pub - Principal Register
-
May 16 2013Examiner's Amendment Entered
-
May 16 2013Notification of Examiners Amendment E-Mailed
-
May 16 2013Examiners Amendment E-Mailed
-
May 16 2013Examiners Amendment -Written
-
Jun 03 2013Law Office Publication Review Completed
-
Jun 03 2013Assigned To Lie
-
Jun 19 2013Notification of Notice of Publication E-Mailed
-
Jun 26 2013Irregularity Notice Received From Ib
-
Jul 09 2013Official Gazette Publication Confirmation E-Mailed
-
Jul 09 2013Published For Opposition
-
Sep 17 2013Irregularity Response Received From Applicant
-
Sep 18 2013Response To Irregularity Reviewed and Accepted
-
Sep 18 2013Irregularity Response Sent To Ib
-
Sep 24 2013Registered-Principal Register
-
Sep 24 2013Trademark officially registered with the USPTO
-
Dec 07 2013Application For Ir Registered By Ib
-
Dec 25 2013Partial Ceasing of Effect To Be Processed
-
Apr 10 2014Ceasing of Effect Reviewed - No Action Required By Office
-
Jun 03 2014Subsequent Designation Received
-
Jun 03 2014Subsequent Designation Sent To Ib
-
Jul 04 2014Subsequent Designation Processed By Ib
-
Feb 21 2015Subsequent Designation Received
-
Feb 21 2015Subsequent Designation Sent To Ib
-
Mar 20 2015Subsequent Designation Processed By Ib
-
Jul 06 2015Subsequent Designation Received
-
Jul 06 2015Subsequent Designation Sent To Ib
-
Aug 21 2015Subsequent Designation Processed By Ib